New hope for kidney disease: Long-Term drug safety trial begins

NCT ID NCT06858319

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 23 times

Summary

This study looks at the long-term safety of a drug called zigakibart for adults with IgA nephropathy, a kidney disease. It is for people who have already finished a previous zigakibart study. Researchers will monitor side effects and check kidney function over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • Colorado Kidney Care Nephrology

    RECRUITING

    Denver, Colorado, 80230, United States

    Contact

  • Dallas Renal Group

    RECRUITING

    Dallas, Texas, 75230, United States

  • Dallas Renal Group

    RECRUITING

    Dallas, Texas, 75230, United States

    Contact Phone: •••-•••-••••

    Contact

    Contact

  • Icahn School of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10029, United States

    Contact

  • Knoxville Kidney Center Pllc

    RECRUITING

    Brentwood, Tennessee, 37027-4528, United States

    Contact

  • NY Nephrology

    RECRUITING

    Clifton Park, New York, 12065, United States

    Contact Phone: •••-•••-••••

    Contact

  • Nephrology Associates Of Central FL

    RECRUITING

    Orlando, Florida, 32806, United States

    Contact

  • Novartis Investigative Site

    RECRUITING

    La Plata, Buenos Aires, B1902COS, Argentina

  • Novartis Investigative Site

    RECRUITING

    Buenos Aires, Buenos Aires F.D., 1280, Argentina

  • Novartis Investigative Site

    RECRUITING

    Santa Fe, S3000EPV, Argentina

  • Novartis Investigative Site

    RECRUITING

    Kuala Lumpur, 59100, Malaysia

  • Novartis Investigative Site

    RECRUITING

    Cheonan, Chungcheongnam-do, 330-721, South Korea

  • Novartis Investigative Site

    RECRUITING

    Guri-si, Gyeonggi-do, 471-701, South Korea

  • Novartis Investigative Site

    RECRUITING

    Seongnam-si, Gyeonggi-do, 13620, South Korea

  • Novartis Investigative Site

    RECRUITING

    Seoul, Seoul, 03080, South Korea

Conditions

Explore the condition pages connected to this study.